Five stocks witnessing long built-up
Five stocks witnessing long built-up

Five stocks witnessing long built-up

DSIJ Intelligence Article rating: 3.8

The market opened in red on April 23, 2021, overall volumes in futures & options currently stand at 9,98,78,806 contracts with a turnover of Rs. 88,49,231.75 crore.

Five stocks witnessing short built-up
Five stocks witnessing short built-up

Five stocks witnessing short built-up

DSIJ Intelligence Article rating: 4.4

The market opened in red on April 23, 2021, overall volumes in futures & options currently stand at 9,98,78,806 contracts with a turnover of Rs. 88,49,231.75 crore.

Greenpanel Industries: A multibagger that keeps on outperforming
Greenpanel Industries: A multibagger that keeps on outperforming

Greenpanel Industries: A multibagger that keeps on outperforming

DSIJ Intelligence Article rating: 3.9

Greenpanel Industries is a market leader of MDF segment in India. MDF stands for medium-density fibreboard. On a YTD basis, the company's stock is up by nearly 70 per cent while in one year, it is up by more than 600 per cent. 

These pharma stocks are trading at their 52-week highs
These pharma stocks are trading at their 52-week highs

These pharma stocks are trading at their 52-week highs

DSIJ Intelligence Article rating: 3.7

Sustaining through this pandemic, pharma companies are the ones, which are witnessing an increase in their revenue as well as the overall business due to production of medicines & vaccines.

Caplin Point rises after its subsidiary gets USFDA nod for generic version of Bloxiverz injection
Caplin Point rises after its subsidiary gets USFDA nod for generic version of Bloxiverz injection

Caplin Point rises after its subsidiary gets USFDA nod for generic version of Bloxiverz injection

DSIJ Intelligence Article rating: 4.0

On Thursday, Caplin Point Laboratories announced that its subsidiary, Caplin Steriles Limited has been granted final approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Neostigmine Methylsulfate injection.   

RSS
First25122513251425152517251925202521Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR